Therapex Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://therapexbio.net
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients
Phase 1
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungEGFR Mutant Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2023-12-29
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Therapex Co., Ltd
- Target Recruit Count
- 115
- Registration Number
- NCT06186076
- Locations
- 🇰🇷
Chungbuk National University Hospital, Chungju, Chungbuk, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam, Kyeongki, Korea, Republic of
🇰🇷The Catholic University of Korea St. Vincent Hospital, Suwon, Kyeongki, Korea, Republic of
News
No news found